NCT02878369

Brief Summary

In order to identify the responding patients with vascular filling test, this research aims to compare the performance of the increased flow in the femoral artery to the performance of the blood pressure increase. The reference measurement will increase cardiac output measured by ultrasound.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2016

Completed
Last Updated

August 25, 2016

Status Verified

August 1, 2016

Enrollment Period

1.9 years

First QC Date

August 22, 2016

Last Update Submit

August 24, 2016

Conditions

Keywords

fluid replacement

Outcome Measures

Primary Outcomes (1)

  • In the intensive care patient of acute circulatory failure signs, assess the increase of the femoral arterial flow (specifically its full-time speed, ΔRVAFitv measured by Doppler ultrasound) to identify responders this fluid replacement.

    First patient enrollment: april 2014 - Study duration: 24 month - Patient follow-up: 30 minutes

Interventions

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

One hundred and twenty adult patients hospitalized in one of the participating ICUs, will be included (see the justification required number of subjects in "statistics") if * They are already carrying an intra-arterial catheter (femoral or radial). * They exhibit acute circulatory failure signs (see below) * The doctor in charge prescribed a vascular fluid replacement, regardless of the purposes of the study: * vascular fluid replacement * initiation or catecholamine * or increase (\> 10%) of catecholamine dosage.

You may qualify if:

  • Patient hospitalized in intensive care and affiliated to a social security system
  • Intra-arterial catheter already in place and operational
  • Stability blood pressure for 5 min (no change in mean arterial pressure\> 10%, no increase in dose catecholamine)
  • Presence of at least one sign of acute circulatory failure from:
  • Low blood pressure (mean arterial pressure \<65 mmHg and / or systolic \<90 mmHg)
  • tachycardia\> 120 bpm without other obvious cause a circulatory failure
  • Oliguria \<1 ml / kg during the last hour suggestive of circulatory failure
  • blood Hyperlactataemia\> 2 mmol / l without other obvious cause a systemic circulatory failure (lactate will not be measured for the purposes of the study)
  • Smear
  • ongoing catecholamine Administration
  • Another sign justifying, according to the doctor in charge, vascular filling test (capillary refill time elongated, others ...)
  • The doctor in charge has prescribed a fluid loading test, regardless of the needs of the study.
  • Clear contraindication to the femoral artery Doppler (wound or burn the groin, for example)
  • Complete occlusion of the femoral artery or 2 of the aorta requiring or having required a vascular bypass
  • Pregnant woman
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nantes

Nantes, 44000, France

RECRUITING

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Karim LAKHAL, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2016

First Posted

August 25, 2016

Study Start

April 1, 2014

Primary Completion

March 1, 2016

Last Updated

August 25, 2016

Record last verified: 2016-08

Locations